UBS Group Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRGFree Report) had its price target raised by UBS Group from $500.00 to $560.00 in a research note released on Monday morning. They currently have a neutral rating on the medical equipment provider’s stock.

Other analysts have also recently issued reports about the stock. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Piper Sandler reiterated an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday. Finally, Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Read Our Latest Analysis on ISRG

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $573.48 on Monday. The stock has a market cap of $204.26 billion, a price-to-earnings ratio of 92.20, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical has a 1 year low of $364.17 and a 1 year high of $616.00. The business has a fifty day moving average of $547.16 and a 200-day moving average of $505.21.

Insider Activity

In other news, insider Jamie Samath sold 22,903 shares of the stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the sale, the insider now owns 8,757 shares in the company, valued at $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 42,265 shares of company stock worth $21,964,281 over the last quarter. 0.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

Hedge funds have recently modified their holdings of the stock. Mirador Capital Partners LP raised its position in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the period. M.E. Allison & CO. Inc. purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth $449,000. Seilern Investment Management Ltd bought a new stake in Intuitive Surgical during the fourth quarter valued at $82,517,000. Exome Asset Management LLC raised its holdings in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares in the last quarter. Finally, Consolidated Planning Corp increased its position in shares of Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.